Evidence map›Paper›PMID 32078194›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2020

A novel nicastrin mutation in a three-generation Dutch family with hidradenitis suppurativa: a search for functional significance.

A R J V Vossen, K R van Straalen, S M A Swagemakers, J E M M de Klein, A P Stubbs, D J Venter, H H van der Zee, P J van der Spek, E P Prens

Open access · hybridAbstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Genetic factors associated with hidradenitis suppurativa, a literature review.International journal of women's dermatology · 2024
    Review
  5. Article
  6. Review
  7. [Pathogenesis of hidradenitis suppurativa/acne inversa].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Review
  8. Review
  9. Dermato-venereology in the year of coronavirus - Hot topics in research and patient care.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

A R J V VossenDepartment of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-1448-5972
K R van StraalenDepartment of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0003-3305-3814
S M A SwagemakersDepartment of Pathology and Clinical Bioinformatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
J E M M de KleinDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
A P StubbsDepartment of Pathology and Clinical Bioinformatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
D J VenterDepartment of Pathology, Mater Health Services, South Brisbane, Queensland, Australia.
H H van der ZeeDepartment of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
P J van der Spek *Department of Pathology and Clinical Bioinformatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
E P Prens *Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLMater Health Services · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMutations in the γ-secretase enzyme subunits have been described in multiple kindreds with familial hidradenitis suppurativa (HS).

objectiveIn this study, we report a novel nicastrin (NCSTN) mutation causing HS in a Dutch family. We sought to explore the immunobiological function of NCSTN mutations using data of the Immunological Genome Project.

methodsBlood samples of three affected and two unaffected family members were collected. Whole-genome sequencing was performed using genomic DNA isolated from peripheral blood leucocytes. Sanger sequencing was done to confirm the causative NCSTN variant and the familial segregation. The microarray data set of the Immunological Genome Project was used for thorough dissection of the expression and function of wildtype NCSTN in the immune system.

resultsIn a family consisting of 23 members, we found an autosomal dominant inheritance pattern of HS and detected a novel splice site mutation (c.1912_1915delCAGT) in the NCSTN gene resulting in a frameshift and subsequent premature stop. All affected individuals had HS lesions on non-flexural and atypical locations. Wildtype NCSTN appears to be upregulated in myeloid cells like monocytes and macrophages, and in mesenchymal cells such as fibroblastic reticular cells and fibroblasts. In addition, within the 25 highest co-expressed genes with NCSTN we identified CAPNS1, ARNT and PPARD.

conclusionThis study reports the identification a novel NCSTN gene splice site mutation which causes familial HS. The associated immunobiological functions of NCSTN and its co-expressed genes ARNT and PPARD link genetics to the most common environmental and metabolic HS risk factors which are smoking and obesity.

Indexed as

Hidradenitis SuppurativaAmyloid Precursor Protein SecretasesCalpainHumansMembrane GlycoproteinsMutationTranscription FactorsAmyloid Precursor Protein SecretasesCalpainCAPNS1 protein, humanMembrane GlycoproteinsTranscription Factors

Identifiers

PMID32078194
PMCPMC7586943
OpenAlexW3006857762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.